When are we launching 3831??

Quote

anonymous

Guest
It’s April 11th, we haven’t heard any potential launch date, training maybe the 3rd week of July. What the hell is going on, I bet this drug doesn’t get approved. #fingerscrossed. It’s going to suck selling another shitty drug. Buts there’s 2% less weight gain and your patients can’t be on opioids. They don’t do opioids right?? No one does opioids in Merica.....
 






Come on!!! Who doesn't need a $40 a pill drug that is no better than the 9 cent generic pill that has been on the market for decades. I'm surprised the FDA didn't give us an expedited review. If it does get approved, it's gonna suck having to sell it.
 


















This drug has the potential to launch so miserably that we just may stop promoting it 9 months post launch. I still think the FDA is going to do something to make sure this isn't approved of if they do approve it will have major label changes and full REMs program.
 












anonymous said:
Come on!!! Who doesn't need a $40 a pill drug that is no better than the 9 cent generic pill that has been on the market for decades. I'm surprised the FDA didn't give us an expedited review. If it does get approved, it's gonna suck having to sell it.
Click to expand...

Hey, people were duped into buying bottled water even though it’s free from the tap.
 


















Seems to me launching 3831 is just being done to keep investors off management's back until they see launching generic olanzapine with samidorphan on it for 40 times the price of generic olanzapine and only slightly reducing weight gain with no positive effects on metabolic was a very bad idea. Let's no even get started on if samidorphan will throw people using illicit opioids into withdrawal when taken. Or how about no contracting strategy of any sort. Or... Oh forget it... This drug is dead if it is approved. I think management already knows it too.
 






anonymous said:
Seems to me launching 3831 is just being done to keep investors off management's back until they see launching generic olanzapine with samidorphan on it for 40 times the price of generic olanzapine and only slightly reducing weight gain with no positive effects on metabolic was a very bad idea. Let's no even get started on if samidorphan will throw people using illicit opioids into withdrawal when taken. Or how about no contracting strategy of any sort. Or... Oh forget it... This drug is dead if it is approved. I think management already knows it too.
Click to expand...

Pops is trying to save his oily hide. Nothing more, nothing less.
 






anonymous said:
Pops is trying to save his oily hide. Nothing more, nothing less.
Click to expand...
This drug could very well be the worst drug I have ever had in my bag in over 19 years in this industry. I've had some really bad ones, too. This one is the worst by far. I hope it doesn't get approved and I can just keep my focus on Aristada. I've never wished a drug not to get approved by a company I worked for. This is a first.
 






















































Top Bottom
Back
Quote